Veronika Lukacs-Kornek

5PUBLICATIONS
31CO-AUTHORS
Molecular targetsIntensive careEpigenetics (incl. genome methylation and epigenomics)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 09, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Jun 13, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma.

Racha Hosni, Niklas Klümper, Christine Sanders

|Jan 03, 2025
Liquid biopsy in organ damage: introduction of an innovative tool for assessing the complexity of blunt splenic injury.

Aliona Wöhler, Bingduo Wang, Robert Schwab

|Dec 19, 2024
Isolation, Purification, and Comprehensive Flow Cytometry Assessment of Lung Stromal Cells.

Sophia Rottmann, Veronika Lukacs-Kornek

|Mar 26, 2019
The tumour microenvironment and immune milieu of cholangiocarcinoma.

Luca Fabris, María J Perugorria, Joachim Mertens

Pageof 1